MedPath

山东化药医药科技有限公司

Ownership
-
Established
2018-08-15
Employees
-
Market Cap
-
Website
www.sdscmr.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20254228
Approval Date
May 20, 2025
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20254229
Approval Date
May 20, 2025
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20254227
Approval Date
May 20, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.